leisure time -WSS

leisure time

author：comprehensive 2025-09-14 15:17:58 - browse：374

Illustration of two DNA strands made of banknotes. -- health coverage from STAT — Adobe

The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason.

But last year, they sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’s runaway drug spending.

It was a testament to the power of a new class of gene therapies to deliver something pharma so rarely does: Genuine cures. The treatment, approved last week as Lenmeldy, may allow some babies born with an ultra-rare neurodegenerative disease called metachromatic leukodystrophy, or MLD, to grow up and live essentially normal lives.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

WSS

Flagship Pioneering startup Sonata Therapeutics lays off 21

In 'major milestone,' FDA approves first cell therapy for solid tumors

Truvian presents data for its desktop blood

Abridge raises $150m as clinical notes automation market heats up

CDC Director Mandy Cohen on transparency, trust, and health

Rise in cancer among younger people worries and puzzles doctors

knowledge

leisure time

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Will the FTC rein in IQVIA's health data empire?

Trump demands the U.S. pay no more for drugs than other countries … again

MD Anderson's Padmanee Sharma responds to research credit suit

Alkermes shareholders re

MD Anderson's Padmanee Sharma responds to research credit suit

Medicare details structure of new drug price negotiation program

Reporting on presidential health from Reagan to Trump and Biden

Alkermes shareholders re

Opioid cravings were reduced by anti

explore

Senate panel puts off hardest PBM reforms for another day

Surprise medical billing ban raises prices elsewhere

Truvian presents data for its desktop blood

In the gardens at Boston Children's Hospital, families find sanctuary

New study raises questions about niacin and heart health

UHS says company favors patients whose insurance pays more

focus

hotspot

Wikipedia

leisure time